Eagle Bay Advisors’s BioNTech BNTX Stock Holding History

Eagle Bay Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-112	Closed	-$12.8K	–	229
2024 Q4	$12.8K	Hold	112	–	–	0.01%	533
2024 Q3	$13.3K	Hold	112	–	–	0.01%	724
2024 Q2	$9K	Hold	112	–	–	0.01%	580
2024 Q1	$10.3K	Hold	112	–	–	0.01%	574
2023 Q4	$11.8K	Hold	112	–	–	0.01%	493
2023 Q3	$12.2K	Hold	112	–	–	0.01%	575
2023 Q2	$12.1K	Hold	112	–	–	0.01%	581
2023 Q1	$14K	Sell	112 -68	-38%	-$9.34K	0.01%	559
2022 Q4	$27K	Sell	180 -22	-11%	-$3.38K	0.02%	490
2022 Q3	$27K	Sell	202 -18	-8%	-$2.75K	0.02%	456
2022 Q2	$32.8K	Buy	+220	New	+$33.6K	0.02%	459
2022 Q1	–	Sell	-107	Closed	-$38K	–	383
2021 Q4	$38K	Buy	107 +7	+7%	+$1.92K	0.02%	442
2021 Q3	$27K	Hold	100	–	–	0.02%	540
2021 Q2	$23K	Buy	+100	New	+$18.9K	0.02%	507

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Eagle Bay Advisors's BNTX Position: Q1 2025 in Review

Eagle Bay Advisors sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 112 shares — an estimated $12.8K sold.

Eagle Bay Advisors first reported a position in BNTX in Q2 2021 and held it in 14 quarters. The position peaked at $38K in Q4 2021. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

Eagle Bay Advisors reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
Eagle Bay Advisors sold 112 BioNTech shares in Q1 2025, an estimated $12.8K.
Eagle Bay Advisors first reported a position in BioNTech in Q2 2021 and held it in 14 quarters.
Eagle Bay Advisors's BioNTech position peaked at $38K in Q4 2021.
280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.